title: Has the change to acellular pertussis vaccine improved or worsened pertussis control?
authors.affiliation: Canadian Center for Vaccinology, Dalhousie University and the IWK Health Centre, Halifax, NS. scott.halperin@dal.ca
authors.forename: Scott A
authors.initials: SA
authors.lastname: Halperin
authors.forename: Gaston
authors.initials: G
authors.lastname: De Serres
mesh_terms: D002170:Canada / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D004196:Disease Outbreaks; D005260:Female; D006801:Humans; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D010567:Pertussis Vaccine / Q000276:immunology / Q000627:therapeutic use*; D011159:Population Surveillance; D022282:Vaccines, Acellular; D014917:Whooping Cough / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission
chemical_list: D010567:Pertussis Vaccine; D022282:Vaccines, Acellular